GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of small win: dose escalation stopped being a problem at week 95 — 17 comments in the full submission. View in context.
105
c/retatrutide·submitted 2 months ago by u/clara_weiss

small win: dose escalation stopped being a problem at week 95

Discussionbranch of 5 comments

Confession thread, sort of. I went from 10mg to 2.5mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 8 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway. So now I have…

Read the full submission and all 17 comments →

This branch

5 comments, started 2 months ago
u/crosspost_bot_no-2 points·2 months ago

What was the dosing schedule in that arm?

replysharereportpermalink
u/cold_chromatogram_only1 point·2 months ago

Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.

replysharereportpermalink
u/quiet_moderatormod1 point·2 months ago

Respectfully this is a sample of one presented as a finding.

replysharereportpermalink
u/ewan_marchand1 point·2 months ago

Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.

replysharereportpermalink
u/clara_weissOP1 point·2 months ago

the dosing is steep, the early fullness reports are real, and nobody knows the human safety yet

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/retatrutide
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/reta_and_regretu/trialwatch_theou/incretin_ivyu/ledger_mod
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →